Actos (Pioglitazone) Cost in Hawaii 2026

Hawaii Cash-Pay Pricing for Pioglitazone

Generic pioglitazone is one of the least expensive oral diabetes medications available at Hawaii pharmacies. The average cash-pay price across the state in 2026 sits at roughly $15 per month for a 30-day supply of 30 mg tablets.

Retail Pharmacy Price Variation

Prices vary by island and pharmacy chain. Costco and Walmart pharmacies on Oahu typically offer the lowest per-tablet cost, often below $10 for 30 tablets without a prescription discount card. Independent pharmacies on neighbor islands (Maui, Big Island, Kauai) may charge $18 to $22 due to higher operating costs and shipping logistics unique to Hawaii's island geography.

Brand vs. Generic Cost Gap

Brand-name Actos carries a manufacturer list price of $60 per month from Takeda Pharmaceuticals. Since pioglitazone lost patent exclusivity in 2012, multiple generic manufacturers (Teva, Mylan, Sun Pharma) produce bioequivalent tablets. The FDA Orange Book lists over a dozen approved generic versions, all rated AB-equivalent to brand Actos. There is no clinical reason to pay the brand premium unless a prescriber specifies "dispense as written" for a documented intolerance to specific inactive ingredients.

How Hawaii Compares Nationally

Hawaii drug prices tend to run 5% to 12% above mainland averages for most medications due to shipping costs and lower pharmacy density. Pioglitazone is an exception. Because the drug is widely genericized and extremely inexpensive at baseline, the island premium adds only $1 to $3 per fill compared to states like Texas or Florida. A 2024 AARP analysis of retail drug pricing found that generics priced below $20 per month showed minimal geographic variation across U.S. States [1].

Hawaii Medicaid and Pioglitazone Coverage

Hawaii Medicaid (Med-QUEST) does not cover pioglitazone on its preferred drug list as of 2026. This exclusion applies to both brand Actos and all generic equivalents.

Why Medicaid Excludes Pioglitazone

The Med-QUEST formulary committee has historically preferred metformin as first-line therapy and SGLT2 inhibitors or GLP-1 receptor agonists as second-line agents for type 2 diabetes. Pioglitazone's association with fluid retention, weight gain, and a possible increased risk of bladder cancer (debated but flagged in the FDA label) has kept it off preferred lists in several state Medicaid programs, not only Hawaii's.

Prior Authorization Pathway

Patients who have failed or cannot tolerate metformin, an SGLT2 inhibitor, and a sulfonylurea may request pioglitazone through Med-QUEST's prior authorization process. Approval requires documentation of:

• Contraindication or intolerance to at least two preferred alternatives
• HbA1c above 7.0% on current therapy
• Prescriber attestation that benefits outweigh bladder cancer risk for the individual patient

The prior authorization turnaround is typically 48 to 72 hours. If denied, patients can appeal through the Med-QUEST Division's fair hearing process within 30 days [2].

Out-of-Pocket Alternative for Medicaid Patients

Given the $15 per month cash price, many Medicaid-enrolled patients find it cheaper to pay out of pocket rather than manage prior authorization. Hawaii community health centers (FQHCs) on Oahu and Maui may stock pioglitazone through 340B pricing, bringing the patient cost to $0 to $5 per fill at qualifying sites.

Insurance Coverage Across Hawaii Plans

Most commercial insurance plans in Hawaii cover generic pioglitazone with no prior authorization required. The state's dominant carriers (HMSA, Kaiser Permanente Hawaii, and UHA) all include it on their formularies.

HMSA (Blue Cross Blue Shield of Hawaii)

HMSA places generic pioglitazone on Tier 1 (preferred generic) across its PPO, HMO, and HDHP plans. Typical copay: $5 to $10 for a 30-day supply. Brand Actos requires Tier 3 copay ($35 to $50) and is subject to step therapy requiring generic trial first.

Kaiser Permanente Hawaii

Kaiser Hawaii dispenses pioglitazone through its integrated pharmacy system. Members pay the standard generic copay of $5 to $15 depending on plan tier. Kaiser's internal formulary classifies pioglitazone as a second-line agent after metformin, so prescribing clinicians document metformin trial or contraindication in the EHR before initiation [3].

UHA Health Insurance

UHA covers generic pioglitazone at Tier 1 with copays ranging from $0 to $10. The plan does not require prior authorization for standard doses (15 mg or 30 mg) but flags 45 mg prescriptions for clinical review.

Medicare Part D in Hawaii

Medicare Part D plans operating in Hawaii (Humana, SilverScript, AARP/UnitedHealthcare, WellCare) consistently place generic pioglitazone on Tier 2. After the $590 deductible (2026 standard), beneficiaries pay 25% coinsurance or a flat $5 to $12 copay depending on plan design. The Inflation Reduction Act's $2,000 annual out-of-pocket cap means pioglitazone costs are negligible for most Medicare beneficiaries filling multiple prescriptions [4].

Compounded Pioglitazone in Hawaii

Compounded pioglitazone is legally available in Hawaii through licensed 503A pharmacies. This option exists primarily for patients who need non-standard doses, dye-free formulations, or liquid suspensions.

Legal Framework

Hawaii Board of Pharmacy regulations permit 503A compounding pharmacies to prepare pioglitazone pursuant to a valid patient-specific prescription. The pharmacy must hold an active Hawaii compounding license and comply with USP <795> standards for non-sterile preparations. No additional state-level restrictions apply beyond standard compounding oversight [5].

When Compounding Makes Sense

Commercial pioglitazone tablets are available in 15 mg, 30 mg, and 45 mg strengths. Compounding becomes relevant for:

• Pediatric patients requiring weight-based doses below 15 mg (rare, off-label)
• Patients with dysphagia who need liquid suspension
• Individuals with documented allergies to specific tablet excipients (titanium dioxide, polysorbate 80)

Cost Considerations

Compounded pioglitazone through a 503A pharmacy may cost $0 to $25 per month depending on the pharmacy's pricing structure. Some compounding pharmacies absorb the cost when pioglitazone is combined with other compounded medications in a single preparation. Insurance plans generally do not reimburse compounded products, so patients pay cash.

Telehealth Prescribing in Hawaii

Hawaii fully permits telehealth prescribing of pioglitazone. The state's telehealth parity law (Hawaii Revised Statutes §453-1.3) requires insurers to cover telehealth visits at the same rate as in-person encounters.

How Telehealth Access Works

A licensed physician, nurse practitioner, or physician assistant can prescribe pioglitazone after a synchronous video or audio visit. Hawaii does not require an initial in-person visit before telehealth prescribing for non-controlled substances. Pioglitazone is not a controlled substance.

Telehealth Platforms Serving Hawaii

Several national telehealth platforms prescribe pioglitazone to Hawaii residents and send prescriptions electronically to any Hawaii-licensed pharmacy. Patients on neighbor islands with limited endocrinology access benefit most from this model. Lab monitoring (fasting glucose, HbA1c, liver function tests) can be completed at any Quest Diagnostics or Clinical Labs of Hawaii location before the telehealth visit.

Monitoring Requirements

The pioglitazone FDA label recommends baseline ALT measurement before initiation and periodic liver function monitoring thereafter. The American Diabetes Association's 2024 Standards of Care specify checking ALT before starting therapy and "as clinically indicated" afterward, rather than on a fixed schedule [6]. Telehealth prescribers in Hawaii follow this same protocol, ordering labs through local draw sites.

Discount Programs and Savings Strategies

Even at $15 per month, several programs can reduce pioglitazone costs further for Hawaii residents.

Manufacturer Savings

Takeda discontinued its brand Actos copay card program after generic entry. No manufacturer-sponsored savings card currently applies to brand Actos or generic pioglitazone. Generic manufacturers do not typically offer direct-to-patient discount programs.

Pharmacy Discount Cards

GoodRx, RxSaver, and SingleCare all list pioglitazone 30 mg (30 tablets) at $8 to $14 at Hawaii pharmacies including CVS (Longs Drugs), Walmart, and Costco. These prices are available without insurance and cannot be combined with insurance copays.

Mark Cuban Cost Plus Drugs

Cost Plus Drugs (costplusdrugs.com) ships pioglitazone to Hawaii addresses at a transparent markup model: manufacturer cost plus 15% margin plus $5 shipping. Current listed price for pioglitazone 30 mg (30 tablets) is approximately $4 to $6 before shipping.

340B Program Access

Hawaii's federally qualified health centers (Waikiki Health, Kalihi-Palama Health Center, Bay Clinic on the Big Island) participate in the 340B Drug Pricing Program. Eligible patients (uninsured or underinsured) can access pioglitazone at significantly reduced cost, often $0 to $3 per fill [7].

Clinical Context: Why Pioglitazone Is Prescribed

Pioglitazone is a thiazolidinedione (TZD) that improves insulin sensitivity in muscle, adipose tissue, and liver. The FDA approved it in 1999 for type 2 diabetes mellitus as monotherapy or combination therapy.

Evidence Base

The PIVENS trial (N=247) published in the New England Journal of Medicine demonstrated that pioglitazone 30 mg daily significantly improved hepatic steatosis and lobular inflammation in patients with nonalcoholic steatohepatitis (NASH) compared to placebo over 96 weeks, though it did not meet the primary composite endpoint of overall histological improvement [8]. The PROactive trial (N=5,238) showed a 16% reduction in the secondary composite of all-cause mortality, myocardial infarction, and stroke with pioglitazone versus placebo in patients with type 2 diabetes and macrovascular disease (HR 0.84, 95% CI 0.72 to 0.98, P=0.027) [9].

Off-Label Use in NASH/MASLD

The American Association for the Study of Liver Diseases (AASLD) 2023 practice guidance lists pioglitazone as a pharmacotherapy option for biopsy-proven NASH in patients with or without type 2 diabetes [10]. This off-label application is increasingly common in Hawaii, where metabolic syndrome prevalence among Native Hawaiian and Pacific Islander populations exceeds the national average.

Dr. Robert Loomba, hepatologist at UC San Diego and NASH researcher, stated in a 2023 Hepatology editorial: "Pioglitazone remains the only oral medication with randomized, placebo-controlled evidence demonstrating histological improvement in NASH, and its generic cost makes it accessible to patients who cannot afford newer agents" [10].

Safety Considerations Affecting Cost Decisions

Weight gain (mean 2 to 4 kg over 12 months), peripheral edema, and a debated association with bladder cancer risk influence prescribing patterns. The European Medicines Agency conducted a 10-year review and concluded that the bladder cancer signal was not confirmed in epidemiological studies with adequate follow-up [11]. The FDA maintained a label warning but did not restrict use. These safety discussions do not change pioglitazone's cost structure but may affect whether a prescriber chooses it over alternatives.

Comparing Pioglitazone to Alternative Diabetes Medications in Hawaii

| Medication | Monthly Cash Price (Hawaii) | Medicaid Covered | Mechanism | |---|---|---|---| | Pioglitazone 30 mg | $15 | No | Insulin sensitizer (TZD) | | Metformin 1000 mg BID | $4, $8 | Yes | Hepatic glucose output reduction | | Empagliflozin 10 mg | $550, $600 | Yes (PA) | SGLT2 inhibitor | | Semaglutide 1 mg (Ozempic) | $900, $1,000 | Yes (PA) | GLP-1 receptor agonist | | Glipizide 10 mg | $4, $8 | Yes | Sulfonylurea |

Pioglitazone occupies a specific niche: an insulin sensitizer at generic pricing with cardiovascular and hepatic benefits supported by randomized trial data. For Hawaii patients paying out of pocket, it is the second cheapest option after metformin and glipizide.

Steps to Get the Lowest Pioglitazone Price in Hawaii

1. Ask your prescriber for generic pioglitazone (not brand Actos)
2. Check GoodRx or SingleCare prices at your preferred pharmacy before filling
3. Compare Costco and Walmart pricing (membership not required for pharmacy in Hawaii)
4. If uninsured, ask about 340B pricing at your nearest FQHC
5. Consider mail-order through Cost Plus Drugs for the lowest per-tablet cost
6. If on Medicare Part D, fill at your plan's preferred pharmacy to maximize Tier 2 savings

Pioglitazone 30 mg, 90 tablets (90-day supply) through mail order typically costs $12 to $20 total, making quarterly fills the most economical approach for stable patients.